Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 2
1980 3
1981 5
1982 5
1983 4
1984 9
1985 5
1986 2
1987 1
1988 2
1989 4
1990 1
1991 1
1992 5
1993 2
1994 3
1995 4
1996 3
1997 5
1998 4
1999 6
2000 3
2001 7
2002 6
2003 9
2004 5
2005 10
2006 9
2007 3
2008 4
2009 6
2010 14
2011 14
2012 8
2013 6
2014 9
2015 6
2016 7
2017 3
2018 8
2019 3
2020 10
2021 15
2022 10
2023 10
2024 10
2025 10
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant palbociclib in women with operable, hormone receptor-positive breast cancer.
Ueno T, Chow LWC, Han W, Huang CS, Mann GB, Morita S, Haga H, Fakhrejahani E, Kobayashi T, Bando H, Inoue K, Tokiwa M, Suwa H, Aruga T, Minamiguchi S, Yamada Y, Tanabe Y, Takada M, Yamashita T, Iwata H, Chung CF, Takahara S, Tokunaga E, Imoto S, Lee ES, Sagara Y, Kim JH, DeBoer RH, Kim HA, Lai HW, Hou MF, White M, Umeyama Y, Toi M. Ueno T, et al. Among authors: aruga t. Endocr Relat Cancer. 2025 Sep 11;32(9):e240353. doi: 10.1530/ERC-24-0353. Print 2025 Sep 1. Endocr Relat Cancer. 2025. PMID: 40888443 Free PMC article. Clinical Trial.
Early breast cancer.
Suzuki T, Toi M, Saji S, Horiguchi K, Aruga T, Suzuki E, Horiguchi S, Funata N, Karasawa K, Kamata N. Suzuki T, et al. Among authors: aruga t. Int J Clin Oncol. 2006 Apr;11(2):108-19. doi: 10.1007/s10147-006-0564-7. Int J Clin Oncol. 2006. PMID: 16622745 Review.
SERDs for primary breast cancer.
Toi M, Aruga T. Toi M, et al. Among authors: aruga t. Lancet Oncol. 2023 Sep;24(9):947-949. doi: 10.1016/S1470-2045(23)00291-7. Lancet Oncol. 2023. PMID: 37657466 No abstract available.
Placental transmogrification of the lung in AKT1-related Proteus syndrome.
Nakajima T, Nakatani Y, Kasajima R, Nakazato Y, Aruga T, Tokuyama W, Miyagi Y, Chida M. Nakajima T, et al. Among authors: aruga t. ERJ Open Res. 2025 May 6;11(3):00776-2024. doi: 10.1183/23120541.00776-2024. eCollection 2025 May. ERJ Open Res. 2025. PMID: 40337338 Free PMC article.
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Takano T, Masuda N, Ito M, Inoue K, Tanabe Y, Kawaguchi K, Yasojima H, Bando H, Nakamura R, Yamanaka T, Ishida K, Aruga T, Yanagita Y, Tokunaga E, Aogi K, Ohno S, Kasai H, Kataoka TR, Morita S, Toi M. Takano T, et al. Among authors: aruga t. Breast Cancer Res Treat. 2024 Aug;207(1):33-48. doi: 10.1007/s10549-024-07333-7. Epub 2024 May 20. Breast Cancer Res Treat. 2024. PMID: 38767786 Free PMC article. Clinical Trial.
Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM).
Nakayama T, Niikura N, Yamanaka T, Yamamoto M, Matsuura K, Inoue K, Takahara S, Nomura H, Kita S, Yamaguchi M, Aruga T, Shibata N, Shimomura A, Ozaki Y, Sakai S, Takiguchi D, Takata T, Bastanfard A, Shiosakai K, Tsurutani J. Nakayama T, et al. Among authors: aruga t. Breast Cancer. 2024 Nov;31(6):1167-1175. doi: 10.1007/s12282-024-01614-1. Epub 2024 Aug 12. Breast Cancer. 2024. PMID: 39133378 Free PMC article.
272 results